EU regulation pertaining to good manufacturing practices and environmental risk assessment of pharmaceuticals does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a… read more.
There is new evidence that a 50-year-old blood pressure drug could find new purpose as a treatment to mitigate the often life-altering effects of increasingly prevalent PTSD, scientists… read more.
Methenamine hippurate could be as effective as antibiotics for preventing recurrent urinary tract infections (UTIs), according to a recent alert from the National Institute for Health and Care… read more.
Investigators from a large USA Veterans Administration study report that chlorthalidone and hydrochlorothiazide are equally effective in preventing major cardiovascular events in patients with hypertension. The findings were… read more.
Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated adults with COVID-19 infection who are at higher… read more.
Tonia Vincent, Professor of Musculoskeletal Biology & Honorary Rheumatologist at Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), said: ‘Hand osteoarthritis is a common and debilitating… read more.
For many, inhalers are a sort of miracle drug. From gasping for air one minute, to breathing normally the next, patients can experience significant relief after one or… read more.
Compared to other experimental therapies, treatment with the ADHD medication lisdexamfetamine resulted in the lowest risk of hospitalization and death among people with amphetamine addiction, researchers reported on… read more.
In a global study of outcome reporting in clinical trials, a research team at The Hospital for Sick Children (SickKids) has issued updated guidelines on what should be… read more.
Metformin use appears to lower the risk of total joint replacement in patients with type 2 diabetes. Researchers reported this finding on December 19, 2022 in the CMAJ/Canadian… read more.
Researchers from a new meta-analysis of data report that, in addition to its known benefits, sodium glucose co-transporter-2 inhibitor (SGLT2) treatment reduces the risk of adverse kidney and… read more.
Recent findings by UCSF and Arc Institute scientists open up new possibilities for overcoming a fundamental challenge in drug discovery. There can be a tradeoff between optimizing a… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
